Hvis der observeres gastrointestinale bivirkninger, bør behandlingen afbrydes midlertidigt, indtil bivirkningerne er ophørt.
Treatment should be temporarily interrupted if gastrointestinal adverse reactions are observed until these adverse reactions resolve.